Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 51 - 100 out of 1,083

Document Document Title
WO/2010/054452
The invention belongs to the chemical pharmaceutical field, and the new compounds of the pterocarpanquinone family having formula (I) according to the invention can be reduction activated, generating alkylating species in the intracellul...  
WO/2010/035000
Using a combination of Kumada, Suzuki and Biellmann chemistry, various menaquinones can synthesised rapidly and with stereochemical integrity offering a new way of preparing these vitamin K2 components for the pharmaceutical market. In o...  
WO/2010/035000
Using a combination of Kumada, Suzuki and Biellmann chemistry, various menaquinones can synthesised rapidly and with stereochemical integrity offering a new way of preparing these vitamin K2 components for the pharmaceutical market. In o...  
WO/2010/034999
A compound of formula (I) in solid form, preferably crystalline form.  
WO/2010/023686
Disclosed herein discloses a crystalline form of 2-Chloro-3-[4-(4-chlorophenyl) cyclohexyl] [l,4]naphthoquinone and process for preparing the same and use thereof. The present invention also provides a process for producing 2-[4-(4- chlo...  
WO/2010/023686
Disclosed herein discloses a crystalline form of 2-Chloro-3-[4-(4-chlorophenyl) cyclohexyl] [l,4]naphthoquinone and process for preparing the same and use thereof. The present invention also provides a process for producing 2-[4-(4- chlo...  
WO/2010/009492
Atovaquone or a pharmaceutically acceptable salt thereof having a particle size diameter range with a D90 of between greater than 3 to about 10µm.  
WO/2010/001379
The invention provides novel intermediates of atovaquone and use thereof for the preparation of atovaquone  
WO/2010/001378
Provided is a process for the epimerization of the cis isomer of atovaquone, atovaquone intermediates and isomeric mixtures thereof into their corresponding trans-isomers resulting in higher yield of pure atovaquone.  
WO/2009/158348
Methods of treating or suppressing oxidative stress disorders including mitochondrial diseases, impaired energy processing disorders, neurodegenerative diseases and diseases of aging are disclosed, as well as compounds useful in the meth...  
WO/2009/141562
The invention relates to quinones of formula (Ia) or (Ib), in which Formula (Ia) and Formula (Ib) R1 and R2 each independently represent - a hydrogen atom, - a C1-3O alkyl group in which one or more -CH2- linkages, apart from the attachm...  
WO/2009/141562
The invention relates to quinones of formula (Ia) or (Ib), in which Formula (Ia) and Formula (Ib) R1 and R2 each independently represent - a hydrogen atom, - a C1-3O alkyl group in which one or more -CH2- linkages, apart from the attachm...  
WO/2009/118443
The invention relates to oviedomycin derivatives, the method for obtaining same and the use thereof. The invention relates to oviedomycin derivatives obtained by fermentation of recombinant bacterial strains. The invention also relates t...  
WO/2009/118327
Derivatives of formula (I) wherein A is selected from the following rings: and their preparation and their application as antimalarial agents.  
WO/2009/098082
The present invention relates to naphthoquinone derivatives isolated from solid callus cultures from two species of the palaeotropical plant families Dioncophyllaceae and Ancistrocladaceae. It further relates to methods of their producti...  
WO/2009/098082
The present invention relates to naphthoquinone derivatives isolated from solid callus cultures from two species of the palaeotropical plant families Dioncophyllaceae and Ancistrocladaceae. It further relates to methods of their producti...  
WO/2009/068322
The present invention relates to compounds having a 1,4-benzoquinone or 1,4- benzoquinone imine scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds tog...  
WO/2009/063485
The present invention is related to the therapeutic uses of vitamin K, its analogues and derivatives in a diverse array of disease conditions. Vitamin K improves blood perfusion and ameliorates hypoxia in prevention and treatment of cond...  
WO/2009/016083
Disclosed are a method for improving the degradation of natural and/or synthetic polymers or a polymer article made from such polymer(s) by light and/or heat and/or humidity, comprising the incorporation of a compound of formula (I) into...  
WO/2009/007991
Disclosed herein is novel process for preparation of Atovaquone, which process includes reacting 1,4-naphthoquinone with trans-4-(4-chlorophenyl) cyclohexane carboxylic acid followed by halogenation to obtain dihalo-compound, further deh...  
WO/2009/007991
Disclosed herein is novel process for preparation of Atovaquone, which process includes reacting 1,4-naphthoquinone with trans-4-(4-chlorophenyl) cyclohexane carboxylic acid followed by halogenation to obtain dihalo-compound, further deh...  
WO/2009/004900
Disclosed are: an immunoadjuvant which has an excellent function of enhancing the production of an antibody and is highly safe; and a vaccine composition comprising the immunoadjuvant. More specifically disclosed are: an immunoadjuvant c...  
WO/2009/001367
The present invention relates to two novel and stable crystalline forms of atovaquone, to the processes for their preparation and to pharmaceutical compositions comprising them. The present invention also provides crystalline particles o...  
WO/2009/001367
The present invention relates to two novel and stable crystalline forms of atovaquone, to the processes for their preparation and to pharmaceutical compositions comprising them. The present invention also provides crystalline particles o...  
WO/2008/139290
The invention concerns a new process for the preparation of naphthoquinones, in particular an improved process for the preparation of 2,3-disubstituted 1,4- naphthoquinones, in the trans configuration.  
WO/2008/122988
Substantially pure atovaquone and parocess for the preparation thereof is disclosed.  
WO/2008/111515
Disclosed is a simple and highly efficient process for producing an aromatic carbonyl compound, which can produce an aromatic carbonyl compound having a substituent introduced to an aromatic ring adjacent to a carbonyl group. The process...  
WO/2008/107878
Novel cannabinoid-derived quinone derivatives (quinonoid derivatives) having a substituted hydroxyl group, pharmaceutical compositions comprising same and uses thereof as anti-proliferative agents, are provided.  
WO/2008/108105
A specific quinone compound, which contains two quinone groups at ortho positions and has such a characteristic that an electron transfer is caused during a reversible oxidation-reduction reaction, is oligomerized or polymerized. Consequ...  
WO/2007/129269
The present invention relates to an improved process for the preparation of Coenzyme Q. Coenzyme QlO or CoQlO has the chemical name 2- [(all -trans)- 3, 7,l l,15,19,23,27,31,35,39-decamethyl-2, 6, 10, 14, 18, 22, 26, 30, 34, 38 - tetraco...  
WO/2007/125919
Disclosed is a sulfonated polymer having excellent workability and excellent methanol resistance. More specifically, disclosed is an aromatic compound represented by the general formula (1): (1) wherein A, D and E independently represent...  
WO/2007/116750
Disclosed is a material for organic electroluminescent devices which contains a quinone derivative represented by one of the formulae (1)-(3) below. [In the formulae, R1-R16 respectively represent a hydrogen, a halogen, a cyano group, an...  
WO/2007/104242
The invention has disclosed 1,2,3-trihydroxy benzene and its derivatives or pharmaceutically acceptable salts of formula I for zinc ion metal-protease inhibition. These compounds are used for selective depressants of zinc ion metal-prote...  
WO/2007/078679
The present invention provides a convergent method for the synthesis of ubiquinones and ubiquinone analogues. Also provided are precursors of ubiquinones and their analogues that are useful in the methods of the invention. The invention ...  
WO/2007/078679
The present invention provides a convergent method for the synthesis of ubiquinones and ubiquinone analogues. Also provided are precursors of ubiquinones and their analogues that are useful in the methods of the invention. The invention ...  
WO/2007/073651
Disclosed are 4,5-seco abieta diterpene quinones (i.e. saproorthoquinone derivatives) of formula A, B or C, physiological acceptable salts, preparation process and pharmaceutical compositions thereof , wherein in formula A, R1 is CH3, CH...  
WO/2007/032378
A process for producing the compound represented by the following formula (1), which is menatetrenone. It is characterized in that a reaction solution consisting only of a solution obtained by dissolving the compound represented by the f...  
WO/2007/026041
The invention relates to derivative 1,4-dioxaanthracene compounds, mainly 1,4-anthraquinoids, having formula I as tumour cell growth inhibitors. The invention also relates to methods of preparing said compounds, pharmaceutical compositio...  
WO/2007/026041
The invention relates to derivative 1,4-dioxaanthracene compounds, mainly 1,4-anthraquinoids, having formula I as tumour cell growth inhibitors. The invention also relates to methods of preparing said compounds, pharmaceutical compositio...  
WO/2007/017168
A process for the preparation of ubihydroquinones and ubiquinones by condensation of a prenol or isoprenol with a hydroquinone or derivative thereof in the presence of 0.005 - 1.0 mol% of a catalyst which is a Broensted-acid, a Lewis-aci...  
WO/2007/016762
The present invention relates to compounds which are perylenequinone derivatives, their stereoisomers and atropisomers. These compounds can be particularly useful as photosensitizers or sononsensitizers in photodynamic or sonodynamic the...  
WO/2007/016635
The present invention relates to methods for purifying Coenzyme Q10.  
WO/2007/004091
The present invention relates to novel intermediates for the preparation of coenzymes, processes for the preparation of the intermediates and an improved process for the preparation of Coenzymes. The present invention particularly relate...  
WO/2006/132348
It is intended to provide a method of purifying ubiquinone-10 characterized by separating and removing a structural analog of ubiquinone-10 contained in a raw material liquid containing ubiquinone-10 by using an acrylic porous cross-link...  
WO/2006/118167
[PROBLEMS] To provide a method, which can analyze environmental microorganisms in a simple and rapid manner, and an apparatus therefor. [MEANS FOR SOLVING PROBLEMS] An extractor for a quinone compound comprises an extraction vessel (9) i...  
WO/2006/104411
The invention relates to a method for producing 2-methyl-1,4-naphthoquinone by oxidising a 2-methyl-1-naphthol with the aid of oxygen or oxygen-containing gas in an organic solvent medium or in a 2-methyl-1-naphthol melt and intensively ...  
WO/2006/104970
Novel conjugates of doxorubicin and novel doxorubicin immunogens derived from the 13 and 14 positions of doxorubicin and antibodies generated by these doxorubicin linked immunogens all of which are useful in immunoassays for the quantifi...  
WO/2006/097472
The invention relates to novel methods of preventing, treating, or ameliorating medical conditions, including cancer, drug resistance, and parasite infections such as malaria, by administering compounds that are capable of inhibiting glu...  
WO/2006/097472
The invention relates to novel methods of preventing, treating, or ameliorating medical conditions, including cancer, drug resistance, and parasite infections such as malaria, by administering compounds that are capable of inhibiting glu...  
WO/2006/074521
The present invention provides a method of scavenging oxygen (particularly ground state oxygen) in an atmosphere or liquid comprising the steps of: (i) providing a polymeric composition comprising an hydrogenated anthraquinone derivative...  

Matches 51 - 100 out of 1,083